Verastem Inc. Stock
Verastem Inc. Stock
A loss of -2.680% shows a downward development for Verastem Inc..
Verastem Inc. is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
With a target price of 24 € there is potential for a 118.18% increase which would mean more than doubling the current price of 11.0 € for Verastem Inc..
Our community identified positive and negative aspects for Verastem Inc. stock for the coming years. 6 users see the criterium "Worthwhile Investment for the next years" as a plus for the Verastem Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Verastem Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Verastem Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Verastem Inc. | -2.680% | -9.091% | 20.219% | 136.498% | 45.695% | -65.039% | - |
Ardelyx Inc. | 1.320% | 0.305% | 18.209% | 119.818% | 25.121% | 26.877% | - |
Evolus Inc | 0.840% | 0.840% | 15.385% | 27.660% | 32.597% | 61.074% | - |
Salarius Pharmaceuticals Inc. | -6.190% | 3.684% | -7.075% | -65.439% | -29.009% | -98.470% | -99.993% |
Comments
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $32.00 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat